SARS-CoV-2, the bird flu A(H7N9), MPox – several new and worrying diseases have appeared over the past years which are a great challenge to public health. In order to protect the population, the responsible health authorities have a range of measures at hand to fight and prevent epidemics. Besides the development of vaccines and medications, […]
Well prepared for the flu season: diagnostics in the interest of public health At regular intervals, sometimes daily, the latest influenza figures are published. National health authorities around the world collect a variety of patient data. The data are compared with each other or with data from the previous week or from the same time
Currently, many patients are presenting themselves at the doctor’s with symptoms of the common cold, such as cough, runny nose, headache and fever. These symptoms are typical of this time of year and can be caused by a number of different pathogens. In many cases, only differential diagnostics can help to identify the pathogen and
EUROIMMUN chemiluminescence immunoassays (ChLIA) for Alzheimer’s disease (AD) biomarkers provide reliable analytical and clinical performance, as demonstrated in two newly published studies performed in a collaboration between researchers at EUROIMMUN and the Memory Clinic of the University Hospital Magdeburg, Germany. Measurement of the four core biomarkers beta-amyloid (Aβ) 1-40, Aβ1-42, total tau and tau phosphorylated
The number of registered whooping cough cases this year is much higher than it was at the same time last year. After a longer break due to the COVID protection measures, case numbers now return to their pre-pandemic levels in many countries. In Germany, another temporary trend was observed: For 2022/2023 the Robert-Koch-Institut (RKI) notes
